Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2)

SKU: orb348902

Description

Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2) is a research-use monoclonal antibody designed to bind human Her2/ErbB2, also known as HER-2/neu, CD340 or p185HER2. It is suitable for laboratory research involving Her2/ErbB2 detection, assay development, antibody comparison and biosimilar studies. The trastuzumab anti-Her2 antibody framework has been described in the literature, including Carter, P. et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci U S A, 89, 4285-4289 (1992). For research use only. Not for diagnostic, therapeutic or clinical use.

Research Area

Signal Transduction

Images & Validation

Tested ApplicationsELISA, FC, IHC
ReactivityHuman

Key Properties

HostHuman
ClonalityMonoclonal
IsotypeHuman IgG
Clone No.4D5-8 (trastuzumab)
ImmunogenA431 cells (human epidermoid carcinoma) (over)expressing EGFR.
TargeterbB-2 (Her-2/neu)
PurityPurified
ConjugationUnconjugated

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Buffer/PreservativesPBS with 0.02% Proclin 300.
Concentration1 mg/ml
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

CD340; Metastatic lymph node gene 19 protein (MLN 19); Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; p185HER2; EGFR

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2)

Immunohistochemical staining of paraffin embedded human breast tissue using anti-erbB-2 antibody 4D5-8 (trastuzumab) Anti-erbB-2 (Her-2/neu) staining of paraffin embedded human breast tissue using the rabbit-chimeric version of 4D5-8 (trastuzumab) (orb348902). Antigen retreival was achieved by microwaving in citrate buffer (pH6), followed by blocking with protein block serum-free buffer. Primary antibody incubation with orb348902 was carried out at 4 µg/ml for 30 minutes. Samples were then incubated with an anti-rabbit IgG HRP secondary antibody for 20 mins followed by DAB (3, 3′-diaminobenzidine), and counter-staining with haemotoxylin. Weak membrane staining exclusively of ductal epithelial cells may be observed. Recommended concentration, 4-6 µg/ml.

UniProt Details

No UniProt data available

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

IHC
Immunohistochemistry
View Protocol
FC
Flow Cytometry
View Protocol
ELISA
Enzyme-linked Immunosorbent Assay (EIA)
View Protocol

Carter, P. et al. Humanization of an anti-p185HER2 antibody for human cancer therapy Proc Natl Acad Sci U S A, 89, 4285-4289 (1992)

Trastuzumab Biosimilar Antibody, Research Grade (Anti-Her2 / ErbB2) (orb348902)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Available Sizes

Select a size below

0.2 mg
¥ 7,800.00
Free Secondary Antibody (20 ul)0/0

Please add an antibody product to your cart first.

DispatchUsually dispatched within 5-10 working days
Bulk Enquiry